Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Comparison of SYHX2011 and Abraxane in Advanced Breast Cancer
NCT05274893Phase 1Unknown
- Sponsor
- CSPC Ouyi Pharmaceutical
- Start
- Mar 2022
- Primary completion
- Sep 2022
- Modality
- Nanoparticles, Small Molecules
01
Overview
Phase 1, randomised, open-label trial of SYHX-2011 in breast cancer (2 arms), sponsored by CSPC Ouyi Pharmaceutical. Primary endpoints: Maximum Plasma Concentration, Area Under the Curve from time zero to last measurable concentration and 1 more. Status: unknown.
02
Drugs
SYHX-2011
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT05274893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05274893.